<DOC>
	<DOCNO>NCT01087580</DOCNO>
	<brief_summary>The main purpose study find whether add radiation therapy standard treatment chemotherapy prostate cancer tolerate well effective standard treatment chemotherapy alone</brief_summary>
	<brief_title>Docetaxel + Prednisone With Without Radiation Castrate Resistant Prostate Cancer</brief_title>
	<detailed_description>Most physician would consider chemotherapy standard prostate cancer . In study participant receive standard chemotherapy . In addition , half participant also receive radiation therapy . It hop radiation therapy provide additional benefit . The use radiation therapy chemotherapy patient kind cancer consider standard treatment present time . Participants randomize group ( Arms ) computer program . Participants randomize Arm 1 receive chemotherapy alone . Participants Arm 2 receive chemotherapy radiation therapy . Participants group ( Arm 1 Arm 2 ) receive standard chemotherapy docetaxel prednisone . Docetaxel give needle vein arm every 3 week 21 day . Participants take prednisone tablet per day 21 day last dose docetaxel . In addition , participant give drug call dexamethasone twice daily 6 dos help side effect docetaxel . Participants Arm 2 first receive radiation therapy pelvis prostate gland . Radiation therapy deliver day , five day week total 8-9 week . Then begin 4-6 week end radiation therapy , chemotherapy give , describe . In Arms , total number cycle docetaxel prednisone depend upon tumor responds drug . All patient receive minimum three cycle chemotherapy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Participants must diagnosis castrate resistant prostate cancer . Participants must 18 year old old . Biopsy tissue prostate enlarge lymph node may require . Patients must sign study specific informed consent prior study entry . Men childproducing potential must willing consent use effective contraception treatment least 3 month afterwards . Participants prior chemotherapy prostate cancer . Participants prior radiation therapy pelvis .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>non metastatic prostate cancer</keyword>
	<keyword>oligometastatic prostate cancer</keyword>
</DOC>